Analyst firms · Morgan Stanley · MDT
Morgan Stanley MDT price target and rating history
Medtronic plc. (MDT) · Health Care
Morgan Stanley rates Medtronic plc. (MDT) Overweight with a $104 price target, as of its latest action on May 30, 2023. It has published 4 rating actions on MDT since August 2021, including 1 upgrade and 1 downgrade. Across 8 firms with a MDT price target in the last 12 months, the median target is $107.
- Current rating
- Overweight
- Price target
- $104
- Median target, all firms
- $107
- Actions on MDT
- 4
Morgan Stanley price target on MDT
Every Morgan Stanley rating on MDT
- May 30, 2023
- Jan 7, 2022
- Nov 24, 2021
- Aug 25, 2021
How other firms rate MDT
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Piper Sandler | Overweight | $120 | Nov 17, 2026 |
| Barclays | Equal Weight | $95 | Oct 7, 2026 |
| Needham | Buy | $114 | Aug 27, 2026 |
| UBS | Buy | $100 | Jul 28, 2026 |
| BTIG | Buy | $90 | Jun 4, 2026 |
| Goldman Sachs | Neutral | $84 | May 21, 2026 |
| Citigroup | Buy | $117 | Feb 3, 2026 |
| Wells Fargo | Overweight | $114 | Jan 30, 2026 |
| William Blair | Outperform | Jan 6, 2026 |
Questions about Morgan Stanley and MDT
- What is Morgan Stanley's price target for MDT?
- Morgan Stanley's latest stated price target for Medtronic plc. (MDT) is $104, from its action on May 30, 2023.
- What is Morgan Stanley's rating on MDT?
- Morgan Stanley rates MDT Overweight, a bullish rating, as of May 30, 2023.
- When did Morgan Stanley last change its view on MDT?
- On May 30, 2023, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $104.
- How does Morgan Stanley's MDT target compare with other analysts?
- Across 8 firms with a MDT price target in the last 12 months, the median target is $107.
More MDT rating histories
- Piper Sandler3
- Barclays3
- Needham7
- UBS4
- BTIG3
- Goldman Sachs4
- Citigroup6
- Wells Fargo6
- RBC Capital Markets3
- Oppenheimer4
- Raymond James3
- Truist Securities3
- Credit Suisse3
All Morgan Stanley ratingsMDT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.